TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2025
Voltar para busca
Dado oficial do USPTO
OXULAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
15/03/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 41, 42
Data de depósito
26/05/2021
Data de registro
28/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
15/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Oxford, GB
Examinador
SOUDERS, MICHAEL
Unidade examinadora
M60
Localização atual
INTENT TO USE SECTION
Descrição da marca
The mark consists of the word "OXULAR" with a triangle pointed down coming through the top and stopping in the middle of the "O" and with a circle in the middle of the "O".
Titulares e representantes
Titulares
Oxular Limited
Representantes
Jeffrey J. Scepanski Ruggiero McAllister & McMahon LLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of ophthalmological and retinal diseases and conditions; ophthalmic preparations; pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of retinal diseases and disorders
Classe 9
Downloadable computer software to assess the architecture and depth of targeted eye tissue to enable precise delivery of medical products into the eye; downloadable computer software for collectingtransmittingsharingreceivingstreamingdownloadingplayingorganizingdisplayingcollecting and transferring informationdatavideoimagescontent and other content for medicinal and research use; Downloadable webinars in the field of ophthalmology
Classe 10
Medical instruments and apparatus for administering pharmaceutical and ophthalmic preparations and substances; medical instruments and apparatus for administering pharmaceutical and ophthalmic preparations and substances for the prevention and treatment of ophthalmological and retinal diseases and disorders; Medical instruments and apparatus with embedded software for administering pharmacological and ophthalmic preparations and substances for the prevention and treatment of ophthalmological and retinal diseases and disorders
Classe 41
Education servicesnamely providing classesseminarsworkshopsnondownloadable webinars in the field of ophthalmology; training services in the field of ophthalmology; providing online electronic non-downloadable publications in the nature of medical and trade journals in the field of ophthalmology; providing online non-downloadable videos in the field of ophthalmology
Classe 42
Scientific and technological servicesscientific researchanalysistesting in the field of ophthalmology; researchdevelopment and testing in the fields of pharmaceutical and ophthalmic preparations and substances; researchdevelopment and testing in the field of medical instruments and apparatus; researchdevelopment and testing in the fields of retinal therapeuticsdiseases and disorders; medical and scientific researchconducting clinical trials for pharmaceutical and ophthalmic preparations and substances for others; medical and scientific researchconducting clinical trials for retinal therapeuticsdiseases and disorders for others; advisory and consulting services related to scientific and technological servicesscientific clinical trials for others and information technology
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/01/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
23/07/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
23/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/05/2024
PUBO
PUBLISHED FOR OPPOSITION
21/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/04/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/12/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/12/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/12/2023
GNFR
FINAL REFUSAL E-MAILED
05/12/2023
CNFR
FINAL REFUSAL WRITTEN
05/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/11/2023
ALIE
ASSIGNED TO LIE
04/11/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/06/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/04/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/04/2023
CNSI
SUSPENSION INQUIRY WRITTEN
07/04/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/04/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/09/2022
CNSL
SUSPENSION LETTER WRITTEN
08/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2022
GNRT
NON-FINAL ACTION E-MAILED
09/02/2022
CNRT
NON-FINAL ACTION WRITTEN
09/02/2022
DOCK
ASSIGNED TO EXAMINER
08/02/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/07/2021
NWAP
NEW APPLICATION ENTERED
29/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OXULAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.